Xenetic Biosciences, Inc. Quarterly Debt-to-equity in % from Q2 2013 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Xenetic Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q2 2013 to Q3 2024.
  • Xenetic Biosciences, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 12.5 %, a 59.3% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 12.5 +4.66 +59.3% Sep 30, 2024
Q2 2024 11.4 +4.08 +56% Jun 30, 2024
Q1 2024 8.4 +0.83 +11% Mar 31, 2024
Q4 2023 7.94 +0.53 +7.15% Dec 31, 2023
Q3 2023 7.85 +0.45 +6.08% Sep 30, 2023
Q2 2023 7.28 +0.37 +5.35% Jun 30, 2023
Q1 2023 7.58 +0.59 +8.44% Mar 31, 2023
Q4 2022 7.41 +0.14 +1.93% Dec 31, 2022
Q3 2022 7.4 +0.14 +1.93% Sep 30, 2022
Q2 2022 6.91 -1.7 -19.7% Jun 30, 2022
Q1 2022 6.99 -6.53 -48.3% Mar 31, 2022
Q4 2021 7.27 -11.9 -62% Dec 31, 2021
Q3 2021 7.26 -16.1 -68.9% Sep 30, 2021
Q2 2021 8.62 -16.9 -66.2% Jun 30, 2021
Q1 2021 13.5 -16.5 -54.9% Mar 31, 2021
Q4 2020 19.1 -14.2 -42.6% Dec 31, 2020
Q3 2020 23.4 -15.2 -39.4% Sep 30, 2020
Q2 2020 25.5 -18.4 -42% Jun 30, 2020
Q1 2020 30 -9.92 -24.9% Mar 31, 2020
Q4 2019 33.3 -4.82 -12.6% Dec 31, 2019
Q3 2019 38.6 +3 +8.44% Sep 30, 2019
Q2 2019 43.9 +5.4 +14% Jun 30, 2019
Q1 2019 39.9 -0.57 -1.41% Mar 31, 2019
Q4 2018 38.2 -2.04 -5.08% Dec 31, 2018
Q3 2018 35.6 -3.05 -7.9% Sep 30, 2018
Q2 2018 38.5 -8.97 -18.9% Jun 30, 2018
Q1 2018 40.5 -17 -29.6% Mar 31, 2018
Q4 2017 40.2 -57.3 -58.8% Dec 31, 2017
Q3 2017 38.6 -121 -75.7% Sep 30, 2017
Q2 2017 47.5 -122 -72% Jun 30, 2017
Q1 2017 57.5 -108 -65.2% Mar 31, 2017
Q4 2016 97.5 -20.4 -17.3% Dec 31, 2016
Q3 2016 159 +70.7 +79.9% Sep 30, 2016
Q2 2016 169 +110 +186% Jun 30, 2016
Q1 2016 165 +120 +268% Mar 31, 2016
Q4 2015 118 +81.1 +220% Dec 31, 2015
Q3 2015 88.5 +51.3 +138% Sep 30, 2015
Q2 2015 59.2 +20.7 +53.9% Jun 30, 2015
Q1 2015 44.9 +1.46 +3.36% Mar 31, 2015
Q4 2014 36.8 -30.7 -45.5% Dec 31, 2014
Q3 2014 37.2 +7.72 +26.2% Sep 30, 2014
Q2 2014 38.5 +10.4 +36.9% Jun 30, 2014
Q1 2014 43.4 Mar 31, 2014
Q4 2013 67.5 Dec 31, 2013
Q3 2013 29.5 Aug 31, 2013
Q2 2013 28.1 May 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.